CM-Path Industry Engagement Day

On Wednesday 5th October 2016, CM-Path members and industry colleagues from pharmaceutical companies, molecular diagnostic companies, digital pathology vendors and regulatory bodies convened to discuss barriers and solutions to technology uptake in pathology.

These barriers and opportunities have been discussed by the Technology and Informatics of Workstream 4 and objectives have been put in place as a result. These objectives include:

  • Creation of an industry forum to create opportunities for joint working between industry and the pathology community
  • Conduct scoping of current availabilities of molecular diagnostic technologies
  • Conduct scoping of current availability and attitudes towards digital pathology

» Download the agenda here (PDF)

» Read the summary of discussions and CM-Path future actions (PDF)